Physician profile
Mohnish Ramani
NPI 1942357025
$7,180.27
in general payments reported to CMS, 2019-2025
10 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,522 · 2020: $14.34 · 2021: $2,117 · 2022: $1,114 · 2023: $16.52 · 2024: $1,059 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $736 · Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $735.83 |
| Food and Beverage | $677.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,294.00 | 2019-2024 | |
| Seapearl East, INC | $3,222.61 | 2019-2024 | |
| Stryker Corporation | $323.54 | 2019-2025 | Alphavent, Pangea |
| Royal Biologics, INC. | $123.70 | 2025 | |
| Acuitive Technologies, INC | $102.44 | 2025 | |
| Bioventus LLC | $52.88 | 2024-2025 | Durolane, Gelsyn-3 |
| Abbvie INC. | $16.52 | 2023 | |
| Depuy Synthes Sales INC. | $15.78 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.46 | 2022 | |
| Horizon Therapeutics Plc | $14.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohnish Ramani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.